Clinical Trial Update: Validation Study of Frontier X Plus (FX+) Device

View source ↗

Summary

A validation study for the Frontier X Plus (FX+) device in atrial fibrillation is listed as NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Frontier X Plus (FX+)

Snippet

Sponsor: Fourth Frontier Technologies Pvt Ltd. | Conditions: Atrial Fibrillation | Status: NOT_YET_RECRUITING